US PTAB Patent Cases
8,574 decisions indexed
Page 46 of 286 · 8,574 total
ClearCorrect Operating, LLC et al. v.Align Technology, Inc.
ClearCorrect Operating, LLC filed an authorized response opposing Align Technology’s Director Review Request, asserting that the new RPI arguments are untimely and that the Director’s discretionary denial was proper.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
The PTAB has instituted inter partes review on all 15 claims of Inari Medical’s embolism‑treatment patent after finding Imperative Care’s obviousness arguments sufficiently persuasive.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
The PTAB has instituted an inter partes review of Inari Medical’s ’291 hemostasis valve patent after finding Imperative Care’s petition shows a reasonable likelihood of success. All 16 challenged claims are now under review.
Belden Inc. et al. v.CommScope, Inc. of North Carolina
Belden has requested Director Review of an IPR concerning CommScope’s patent 9,266,697. The patent owner may file a limited response within five business days.
Microsoft Corp. v.VirtaMove, Corp.
Microsoft and VirtaMove settled their inter partes review dispute over U.S. Patent 7,519,814. The parties filed a joint motion to terminate, and the Board dismissed the petitions and kept the settlement confidential.
Imperative Care, Inc. v.Inari Medical, Inc. et al.
The PTAB instituted an inter partes review of Inari Medical’s hemostasis valve patent after finding Imperative Care’s likelihood of success on at least one claim. All nine claims are now under review.
United Services Automobile Association v.Auto Telematics Ltd.
Auto Telematics Ltd. has filed a Request for Director Review challenging the PTAB’s institution of an IPR against its vehicle‑telematics patent, arguing the Board misinterpreted claim language and ignored discretionary denial grounds.
Mercedes-Benz Group AG et al. v.Phelan Group, LLC
Mercedes‑Benz and The Phelan Group jointly filed a motion to keep their settlement agreement confidential under 35 U.S.C. § 317(b). The request seeks to separate the agreement from the IPR file and restrict third‑party access.
Amazon.com, Inc. et al. v.Audio Pod IP, LLC
The USPTO denied Amazon's request for Director Review of the PTAB's decision denying institution of multiple IPRs against Audio Pod IP's patents. The order confirms the institution denial remains in effect.
Apple Inc. et al. v.SiOnyx, LLC
Apple and Sony moved to withdraw their IPR petition against SiOnyx’s 9,064,764 patent. The patent owner did not oppose, and the Board is expected to terminate the proceeding at the pre‑institution stage.
Amphenol Corporation v.Credo Technology Group Ltd.
The ITC investigation into switchable‑connectivity phones and tablets was terminated after Ericsson and Apple reached a settlement, prompting the Commission to dismiss the case without further review.
Henri Daussi, LLC v.ECNA, LLC et al.
The PTAB granted the parties’ joint request to keep their settlement agreement confidential after the IPR was terminated by mutual agreement.
Henri Daussi, LLC v.ECNA, LLC et al.
Henri Daussi, LLC and ECNA, LLC settled their dispute over U.S. Patent 9,398,791 B1 and jointly moved to terminate the inter partes review before the Board instituted the trial. The Board granted the motion, dismissing the petition.
Intas Pharmaceuticals, Ltd. et al. v.Atossa Therapeutics, Inc.
The Director denied Intas Pharmaceuticals' request for review of the institution decision in IPR2025-00799, leaving Atossa Therapeutics' Patent 11,261,151 in place.
Amazon.com, Inc. et al. v.Audio Pod IP, LLC
Amazon’s request for Director Review of the PTAB’s denial to institute an IPR against Audio Pod’s audio‑device patent was rejected. The Board affirmed that the Acting Director properly exercised discretionary authority under 35 U.S.C. § 314(a).
Docker Inc. v.Intellectual Ventures II LLC
Docker Inc. and Intellectual Ventures II LLC settled their inter partes review disputes before trial, leading the PTAB to dismiss the IPRs. The settlement covered three patents and the agreements were treated as confidential business information.
Mercedes-Benz Group AG et al. v.Phelan Group, LLC
Mercedes‑Benz and Phelan Group settled their dispute over U.S. Patent 9,908,508, leading the PTAB to terminate the inter partes review that had been instituted earlier in the year.
Belden Inc. et al. v.CommScope, Inc. of North Carolina
The USPTO Director denied Belden's request for review of the earlier decision denying institution of CommScope's patent 9,266,697. The denial upholds the original institution refusal.
Henri Daussi, LLC v.ECNA, LLC et al.
Henri Daussi, LLC and ECNA, LLC filed a joint motion to terminate IPR2025-00807 after reaching a settlement, ending the Board proceeding without a final written decision.
Amphenol Corporation v.Credo Technology Group Ltd.
Amphenol and Credo have settled their IPR dispute over U.S. Patent 11,012,252 and jointly request that the settlement agreement be kept confidential under statutory provisions.
Google LLC v.Sandpiper CDN, LLC
The Director denied Google’s request for review of the institution decision in IPR2025-00806, leaving the Sandpiper CDN patent institution intact.
Amazon.com, Inc. et al. v.Audio Pod IP, LLC
The USPTO denied Amazon’s request for Director Review of the decision denying institution of multiple IPRs involving Audio Pod IP’s patents. The denial applies to all listed proceedings.
Amazon.com, Inc. et al. v.Audio Pod IP, LLC
Amazon and its affiliates have filed a Request for Director Review challenging the USPTO’s new six‑year “settled expectations” rule that led to a discretionary denial of institution for their IPR petition covering patent 10,091,266.
Intel Corporation v.Advanced Cluster Systems, Inc.
The Director denied Intel’s request for rehearing of the discretionary denial and institution decision in IPR2025-00794, leaving the patent challenge uninstated.
Harbor Freight Tools USA, Inc. et al. v.Champion Power Equipment, Inc.
The PTAB granted a settlement motion, terminating the IPRs against Harbor Freight Tools USA Inc. and MWE Investments, LLC, while keeping the settlement agreements confidential. Generac Power Systems remains as the sole petitioner in the related proceedings.
Databricks, Inc. v.ByteWeavr, LLC
Databricks successfully challenged U.S. Patent 8,275,827, leading the PTAB to find all 14 challenged claims unpatentable based on anticipation by the Carter reference and obviousness over Carter and Pitzel.
Intas Pharmaceuticals, Ltd. et al. v.Atossa Therapeutics, Inc.
Intas Pharmaceuticals and Atossa Therapeutics filed a joint request to keep their settlement agreement confidential under 35 U.S.C. §317 and to terminate the pending IPR on patent 11,261,151.
Databricks, Inc. v.ByteWeavr, LLC
Databricks successfully challenged 15 claims of the ’827 patent, finding them obvious over the OceanStore system. Anticipation arguments failed, and the Board adopted broader claim constructions that still rendered the claims unpatentable.
USAA Federal Savings Bank v.PACid Technologies, LLC
USAA Federal Savings Bank and PACid Technologies settled their dispute over U.S. Patent 11,070,530, leading to a joint motion that terminated the IPR proceeding before it was instituted.
Intas Pharmaceuticals, Ltd. et al. v.Atossa Therapeutics, Inc.
Intas Pharmaceuticals challenges Atossa Therapeutics’ endoxifen patent in IPR 2025‑00799. The petitioner argues the Board correctly instituted the case and that the Patent Owner’s new arguments are unsupported. The response seeks denial of the Owner’s request for Director Review.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.